Skip to main content
Clinical Trials/JPRN-UMIN000011459
JPRN-UMIN000011459
Completed
Phase 4

Exploratory study to evaluate the recurrence prediction factor in patients with completely resected colorectal cancer which has adjuvant therapy of XELOX.(KPUM-DS-C03) - Exploratory study to evaluate the recurrence prediction factor in patients with completely resected colorectal cancer which has adjuvant therapy of XELOX.(KPUM-DS-C03)

Kyoto Prefectural University of Medicine Department of Surgery Division of Digestive Surgery0 sites251 target enrollmentAugust 12, 2013

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Colorectal Cancer
Sponsor
Kyoto Prefectural University of Medicine Department of Surgery Division of Digestive Surgery
Enrollment
251
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 12, 2013
End Date
June 30, 2019
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Kyoto Prefectural University of Medicine Department of Surgery Division of Digestive Surgery

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. Prior oxaliplatin therapy 2\. Prior chemotherapy or radiotherapy for colorectal cancer 3\. Brain metastasis or active multiple malignancy 4\. Peripheral nerve disorder 5\. A history of severe drug allergy 6\. Active infectious disease 7\. Significant mental illness 8\. Following complications i) Uncontrolled diabetes ii) Uncontrolled hypertension iii) Interstitial pneumonia iv) Iintestinal tract paralysis or ileus v) Significant heart trouble 9\. Inadequate for study enrollment by the physician

Outcomes

Primary Outcomes

Not specified

Similar Trials